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OBJECTIVES: Acute respiratory failure is present in 5% of patients with acute myocardial infarction and is
responsible for 20% to 30% of the fatal post-acute myocardial infarction. The role of inflammation associated with
pulmonary edema as a cause of acute respiratory failure post-acute myocardial infarction remains to be determined.
We aimed to describe the demographics, etiologic data and histological pulmonary findings obtained through
autopsies of patients who died during the period from 1990 to 2008 due to acute respiratory failure with no
diagnosis of acute myocardial infarction during life.
METHODS: This study considers 4,223 autopsies of patients who died of acute respiratory failure that was not
preceded by any particular diagnosis while they were alive. The diagnosis of acute myocardial infarction was given
in 218 (4.63%) patients. The age, sex and major associated diseases were recorded for each patient. Pulmonary
histopathology was categorized as follows: diffuse alveolar damage, pulmonary edema, alveolar hemorrhage and
lymphoplasmacytic interstitial pneumonia. The odds ratio of acute myocardial infarction associated with specific
histopathology was determined by logistic regression.
RESULTS: In total, 147 men were included in the study. The mean age at the time of death was 64 years. Pulmonary
histopathology revealed pulmonary edema as well as the presence of diffuse alveolar damage in 72.9% of patients.
Bacterial bronchopneumonia was present in 11.9% of patients, systemic arterial hypertension in 10.1% and dilated
cardiomyopathy in 6.9%. A multivariate analysis demonstrated a significant positive association between acute
myocardial infarction with diffuse alveolar damage and pulmonary edema.
CONCLUSIONS: For the first time, we demonstrated that in autopsies of patients with acute respiratory failure as the
cause of death, 5% were diagnosed with acute myocardial infarction. Pulmonary histology revealed a significant
inflammatory response, which has not previously been reported.
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INTRODUCTION
Acute respiratory failure (ARF) is a major cause of death in
patients with a variety of primary underlying diseases (1-4).
The clinical and radiographic findings of ARF are nonspecific
(5-7). Prompt investigation and diagnosis are essential to
improving patient survival (8-10). The complexity of clinical
presentations makes diagnosis a constant challenge for the
clinician (8-10).
It is well known that acute myocardial infarction (AMI)
could be present as ARF in approximately 17% of patients
and is associated with poor short- and long-term prognoses
(11-15). Intrahospital and 1-year mortality have been
observed, respectively, in approximately 17% and 35% of
cases (11,16). The prompt and correct diagnosis of AMI in
patients with a nonspecific presentation of ARF in the
emergency department may improve survival (13,16,17).
The role of inflammation in ARF after AMI has been studied
and may be as important as elevated pressures (17). No
report thus far has described pulmonary findings related to
possible inflammation in such patients.
In this context, we performed a retrospective study of
4,710 autopsies in patients with ARF as the cause of death
who were not diagnosed with an AMI during life to better
describe the demographics, etiological data and associated
histological pulmonary findings and diseases.
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METHODS
Autopsies
The present study was performed at a tertiary healthcare
center. From 1990 to 2008, 26,560 medical autopsies were
performed (annual mean of 1,889 autopsies). We considered
4,710 (17.7%) patients for whom ARF was the cause of death
without any specific related diagnosis while the patient was
alive. The diagnosis of AMI was made in 218 (4.63%) cases.
Histological pulmonary analysis was performed in 210 cases
of AMI. For eight (3.67%) patients, the histological pulmon-
ary findings could not be reviewed because the pulmonary
tissue was not available. In this study, we reviewed all
available microscopic and macroscopic diagnoses made
during the autopsy as well as the medical records of each
patient.
The diagnosis of ARF was made based on the clinical
description and/or death certificate and defined as a
PaO2,60 mmHg or PaCO2.50 mmHg with pH,7.30
while breathing room air (1-3). We excluded patients
younger than one year of age because of the possibility of
congenital heart diseases and hyaline membrane disease.
Individuals who were not diagnosed with ARF and AMI
were also excluded.
Cases of healed myocardial infarction were not included.
We only considered AMI. The macroscopic diagnosis of
AMI was considered mainly during the examination of
transverse ventricular sections. The initial modifications
became more evident after 12 and 24 hours. The ischemic
area could easily be observed (approximately 2 to 6 hours
after AMI) with a nitroblue tetrazolium (NBT) enzymatic
reaction or with triphenyltetrazolium chloride (TTC). The
exact period of evolution is very difficult to determine, but
these two methods allowed us to identify patients who died
between 2 hours and 7 days after a myocardial infarction.
Microscopic analyses were started approximately 3 to
12 hours after death with coagulate necrosis and vacuolar
degeneration. Neutrophil infiltration was more intense
between the second and sixth day. Granulation tissue
became more evident after the second week.
We also obtained data regarding each patient’s age, sex
and major underlying associated diseases (as determined at
the time of autopsy).
The clinical data from patients enrolled in the study were
collected with legal permission after informed consent was
obtained from a family member and after the approval of
the Internal Review Board was obtained.
After a complete review, pulmonary pathological reports
were categorized as follows:
N Diffuse alveolar damage (DAD): diffuse involvement
and the uniform temporal appearance of alveolar
collapse, hyaline membranes, obliterative fibrosis, neo-
septa formation and moderately organizing fibrosis.
N Pulmonary edema (PE): the accumulation of proteinac-
eous fluid in the alveolar spaces, giving rise to the
appearance of a granular, pink coagulate within these
spaces.
N Alveolar hemorrhage (AH): the presence of blood in the
alveolar spaces.
N Lymphoplasmacytic interstitial pneumonia (LPIP):
widened and edematous alveolar septa, usually
accompanied by mononuclear inflammatory infiltrates
composed of lymphocytes, histiocytes, plasma cells
and neutrophils.
All lungs were analyzed by microscopy, even when
medical records indicated the patient’s diagnosis. For at
least four weeks, the lungs were fixed in 10% formalin
prepared in 0.9% saline. We studied a minimum of five
sections per lung (total ten sections per person), regardless
of the presence or absence of morphologically demonstrable
lesions. Paraffin-embedded tissue sections were assessed
following hematoxylin and eosin staining. To document the
presence and distribution of the wide spectrum of infectious
agents to which this population is susceptible, we prepared
a variety of special stains (Periodic acid-Schiff test, immuno-
histochemistry analysis, fluorescence, Ziehl-Neelsen, Gram,
Mucicarmine and Gomori’s methenamine silver stain) for
selected tissue sections. Bacterial bronchopneumonia (BBP)
was defined as the presence of cell consolidation with
polymorphonuclear leukocyte accumulation in bronchioles
and adjacent alveoli. For the diagnosis of cytomegalovirus
and fungal pneumonia, histological evidence of lung
involvement with or without tissue culture was required.
Severe sepsis and/or septic shock were defined as sepsis in
addition to organ dysfunction or a clinical diagnosis of
arterial hypotension, which may or may not result in
aggressive fluid resuscitation. Diagnoses of Mycobacterium
tuberculosis infection and atypical mycobacterial infection
were confirmed using fluorescence and Ziehl-Neelsen tech-
niques as well as Lowenstein-Jensen cultures. The proportion
method and biochemistry were used for the identification of
all positive cultures.
Dilated cardiomyopathy refers to all causes of cardiac
insufficiency associated with dilation of the left ventricle
chamber, not only the idiopathic form. Hypertrophic
cardiomyopathy refers only to cases of genetic disturbance
and not to all cases of ventricular wall thickening.
Statistical analysis
A descriptive analysis of the data included the median,
minimum and maximum values. The probability (odds
ratio) that patients would develop specific histopathological
pulmonary patterns or die of ARF-related pulmonary
alterations was determined by logistic regression. The
variables included the following major diseases and/or
comorbidities that were found: BBP, systemic arterial
hypertension, dilated cardiomyopathy, pulmonary embo-
lism, hypertrophic cardiomyopathy, chronic obstructive
pulmonary disease, diabetes mellitus, sepsis and/or septic
shock and brain stroke. All of the statistical procedures were
performed using SPSS v10.0 statistical software. Statistical
significance was set at 5% (p-value).
RESULTS
In total, 218 autopsies (4.63%) of patients with ARF who
died between 1990 and 2008 were not diagnosed with an
AMI while they were still alive. The patients’ ages ranged
from 16 to 90 years (median of 64). A total of 147 (67.4%)
men and 71 (32.6%) women were included in the study. The
demographic data are listed in Table 1.
We observed a single associated disease other than AMI
in 46 (21.1%) cases, two diseases in 16 (7.3%), three in 16
(7.3%) and four in 8 (3.7%) cases. In 132 (60.6%) patients,
AMI was the only cause of death.
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A total of 158 diseases and/or comorbidities other than
AMI were observed. The major diagnoses in patients with
ARF and AMI are shown in Table 2. BBP was present in
11.9% of patients (26 cases) and was the most frequent
pulmonary complication found at the time of autopsy.
Systemic arterial hypertension was the second most
frequent complication and was observed in 10.1% of
patients (22 cases), followed by dilated cardiomyopathy in
6.9% (15), pulmonary embolism in 6.0% (13), hypertrophic
cardiomyopathy in 4.6% (10), chronic obstructive pulmon-
ary disease in 3.7% (8), diabetes mellitus in 3.7% (8), sepsis
and/or septic shock in 3.2% (7) and stroke in 2.8% (6). Other
diagnoses with minor prevalence accounted for 27.2% of
diseases.
The pulmonary histopathological analysis showed PE in
72.9% (159) of patients, DAD in 17.4% (38), LPIP in 4.1% (9)
and AH in 1.8% (4).
The multivariate analysis showing the significant associa-
tions between AMI and different histopathological findings
is presented in Table 3.
DISCUSSION
The accurate early treatment of ARF remains an
important problem in the management of critical patients.
Despite recent technological advances in tools for diag-
nosis, the autopsy has remained an important complemen-
tary tool for the identification and understanding of
disease. Autopsy studies have revealed important differ-
ences between autopsy findings and the clinical diagnosis
antemortem (18-25). Such diagnostic disagreement can
vary from 10 to 90% depending on the disease and the
population involved (5-10,19-21,26-32). Perkins et al. (19)
showed that among the patients who died in the intensive
care unit, 39% of the cases had major missed diagnoses.
AMI was the main missed diagnosis and was present in
approximately 10% of the cases. In almost every studied
patient with AMI, the clinical diagnosis premortem was
BCP (19). These discrepancies might be attributable to
different clinical manifestations of a single disease and to
poor-quality medical care (5).
In the present study, we observed a prevalence of AMI
nondiagnosis of approximately 5% among patients with
ARF. Others authors have reported similar data (19,22).
A comparison between clinical and autopsy diagnoses in
a cardiology hospital published in 2007 reported that
approximately 5% of deaths were not diagnosed with
AMI. The concordance rate between autopsy and premor-
tem diagnoses of AMI was 71%; among 67% of these cases,
the AMI was only subendocardial (22).
Most analyzed patients were males (67%), and the mean
age was 64 years. The occurrence of ischemic equivalents
such as dyspnea is frequent among female and older
patients (17). The majority of studies showed a median
age between 69 and 80 years among patients with PE after
AMI (11-16). Nevertheless, we observed that most of those
diagnosed were males but that they were not older patients,
as expected, perhaps because of an association with ARF
and death in all cases, which was not considered in other
studies. Flutowski et al. (16) reported a median age of 70
years among patients with PE after AMI. Women accounted
for 54% of cases (16).
In 132 (60.6%) patients, AMI was the only cause of death
as revealed by autopsy. Many diseases and/or comorbid-
ities [158] other than AMI were observed in patients with
ARF. BBP was present in 11.9% of patients and was the most
frequent pulmonary complication found at the time of
autopsy, followed by systemic arterial hypertension (10.1%).
Among patients with ARF, BBP is often the initial cause of
pulmonary disease, but BBP sometimes appears as a
complication of other pathologies, mainly in immunocom-
promised and intubated patients (33-36).
Dilated cardiomyopathy, pulmonary embolism, hyper-
trophic cardiomyopathy, chronic obstructive pulmonary
disease, diabetes mellitus, sepsis and/or septic shock and
brain stroke were also present in many cases. The
prevalence (39.4% of cases) of more than one diagnosis
demonstrates the complexity and severity of illness among
the patients that presented ARF as the cause of death after
AMI. These findings could indicate the necessity of a
different therapeutic strategy for these patients with poor
prognoses (4,13,19,21-24). A study published in 2008
analyzed the use of continuous positive airway pressure
in patients with PE secondary to AMI and reported an
intrahospital mortality of 11%. The authors reported that all
patients who died had associated diagnoses, such as severe
sepsis, BBP, stroke and pulmonary embolism. These
findings are similar to our results (12).
As expected, PE was the most common pattern observed
(72.9% of cases) and was also the most specific finding
associated with AMI, as described previously in other
studies (4,16,17). AMI has been described as the most
important etiologic factor associated with the development
of PE in hospitalized patients (16). AMI is the most frequent
cause of heart failure and PE mainly due to the consequent
elevation of the left ventricular diastolic, venous and
pulmonary capillary pressure. This redistributes fluid from
the pulmonary capillaries to the interstitial and alveolar
space (16,17).
Interestingly, DAD was also associated with AMI. This
trend has not been reported for patients with AMI. This
indicates that an inflammatory response could present as an
Table 1 - Demographic data for autopsied patients with
ARF and AMI.
Sex
Age groups
(years) Male Female Total
1 to 50 28 17 45 (20.6%)
51 to 80 106 45 151 (69.3%)
. 80 13 9 22 (10.1%)
Total 147 71 218
Table 2 - Major diagnoses in patients with ARF and AMI.
Associated diseases Number (% of cases)
BBP 26 (11.9)
Systemic arterial hypertension 22 (10.1)
Dilated cardiomyopathy 15 (6.9)
Pulmonary embolism 13 (6.0)
Hypertrophic cardiomyopathy 10 (4.6)
COPD 8 (3.7)
Diabetes mellitus 8 (3.7)
Sepsis and/or septic shock 7 (3.2)
Stroke 6 (2.8)
*BBP = bacterial bronchopneumonia; COPD = chronic obstructive
pulmonary disease.
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ARF after AMI, as suggested by other authors (11,17,37-40).
Normally, DAD is associated with an intense inflammatory
response, which is sometimes related to the cause of death
and may be associated with an extended AMI. There is an
emerging interest in the role of inflammatory mediators in
AMI. Myocardial injury is in part the result of activation of
the inflammatory system, which involves the production
and release of proinflammatory cytokines, activation of the
complement system, the production of autoantibodies, the
overexpression of major histocompatibility complex mole-
cules, and the expression of adhesion molecules that may
perpetuate the inflammatory state (40). In this context, the
cytokines studied most often in the context of heart failure
are tumor necrosis factor and interleukin-6. Other molecules
such as C-reactive protein, selectins and endothelin-1 are
also related to PE (11,37,40). Some studies have suggested
that interleukin-6 mediates endothelial activation in pul-
monary vessels (11). Endothelin-1 could increase vascular
permeability by inducing the production of leukocyte
adhesion molecules and the consequent activation of
neutrophils, which would amplify the inflammatory
response in the lungs (38). Therefore, larger investigational
studies are needed for a better understanding of inflamma-
tory cytokine activation in the lung after AMI. This
knowledge may play a role in improving patient outcomes
through early diagnosis, timely prevention, and therapeutic
intervention. The use of anti-inflammatory agents in AMI
should be reconsidered, mainly in patients with ARF (40).
AH was also associated with AMI. Nevertheless, we think
that the association with AMI is not as relevant because of
the small number of patients (4 cases).
Further studies are necessary to elucidate the complete
pulmonary physiopathological mechanism involved in AMI
and the development of ARF.
Limitations
First and foremost, this was a retrospective study of
medical reports, for which the quality of information can be
limited. The second limitation of our study is related to
interobserver variability, even taking into account that,
at our institution, all autopsies were performed by the
resident pathologist under the supervision of a senior
pathologist, who also checks the histological analysis to
prepare the final reports. Different opinions can be held by
different observers. In addition, the accuracy of autopsy
findings also depends on the interest and skill of the
pathologist.
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